CD274 and neoplasm: Percentage of PD-L1+ immune cells in the tumor microenvironment correlated with response; prevalence of ≥5% PD-L1 IC score: 32%; prevalence for <1% IC score: 33%; Ventana SP142 PD-L1 assay